Jan Weber
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 2%
- HIV/AIDS drug development and treatment
- SARS-CoV-2 and COVID-19 Research
Papers in
-
- HIV/AIDS drug development and treatment 37
- SARS-CoV-2 and COVID-19 Research 9
- Virology 21
- HIV Research and Treatment 20
- Co-authors
- Miguel E. Quiñones‐Mateu (26 shared papers)Bikram Chakraborty (7 shared papers)Jan Hodek (35 shared papers)Hector Rafael Rangel (6 shared papers)Michael L. Marotta (5 shared papers)Michael M. Lederman (5 shared papers)Patti K. Kiser (3 shared papers)Frank Große (1 shared paper)
- Journals
- Scientific Reports (9 papers)PLoS ONE (5 papers)Antiviral Research (5 papers)Antiviral Therapy (4 papers)Viruses (4 papers)
- Partner nations
- CzechiaUnited StatesGermany
In The Last Decade
Jan Weber
102 papers receiving 2.6k citations
Peers
Comparison fields: 5 of 106
- Virology 614
- Infectious Diseases 790
- Microbiology 247
- Drug Discovery 3
- Biomaterials 114
Countries citing papers authored by Jan Weber
This map shows the geographic impact of Jan Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Weber more than expected).
Fields of papers citing papers by Jan Weber
This network shows the impact of papers produced by Jan Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Weber. The network helps show where Jan Weber may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Weber, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 375 | |
| 2 | 2017 | 364 | |
| 3 | 2001 | 104 | |
| 4 | 2016 | 82 | |
| 5 | 1989 | 75 | |
| 6 | 2005 | 74 | |
| 7 | 2003 | 72 | |
| 8 | 2008 | 69 | |
| 9 | 2012 | 69 | |
| 10 | 2016 | 58 | |
| 11 | 2015 | 57 | |
| 12 | 2016 | 55 | |
| 13 | 2002 | 46 | |
| 14 | 2017 | 44 | |
| 15 | 2006 | 43 | |
| 16 | 2020 | 42 | |
| 17 | 2020 | 40 | |
| 18 | 2002 | 38 | |
| 19 | 2003 | 35 | |
| 20 | HIV type 1 tropism and inhibitors of viral entry: clinical implications. | 2006 | 35 |
About Jan Weber
Jan Weber is a scholar working on Infectious Diseases, Virology, Organic Chemistry, Epidemiology and Molecular Biology, having authored 105 papers that have together received 2.7k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (37 papers), HIV Research and Treatment (20 papers), SARS-CoV-2 and COVID-19 Research (9 papers), Hepatitis B Virus Studies (7 papers), Synthesis and Characterization of Heterocyclic Compounds (6 papers), DNA and Nucleic Acid Chemistry (5 papers), Computational Drug Discovery Methods (5 papers) and Synthesis and biological activity (5 papers). The work is most often cited by research in Virology (614 citations), Infectious Diseases (790 citations), Microbiology (247 citations), Drug Discovery (3 citations) and Biomaterials (114 citations). Jan Weber has collaborated with scholars based in Czechia, United States and Germany. Frequent co-authors include Miguel E. Quiñones‐Mateu, Bikram Chakraborty, Jan Hodek, Hector Rafael Rangel, Michael L. Marotta, Michael M. Lederman, Patti K. Kiser, Frank Große, Zhimin Feng and Kathy Medvik. Their work appears in journals such as Scientific Reports, PLoS ONE, Antiviral Research, Antiviral Therapy and Viruses.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.